Significant interactions and main effects of day. حسب Grace Hecker (18813445)

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

Data_Sheet_1_Decreased Proliferation in the Neurogenic Niche, Disorganized Neuroblast Migration, and Increased Oligodendrogenesis in Adult Netrin-5-Deficient Mice.pdf حسب Shunsuke Ikegaya (9693881)

"…The number of proliferating (EdU-labeled) cells in NTN5 KO mice was significantly lower in the V-SVZ, whereas the number of Ki67-positive proliferating cells was unchanged, suggesting a longer cell cycle and decreased cell division in NTN5 KO mice. …"

Areas within one-way public transit travel time thresholds to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. حسب Marcus A. Bachhuber (8339127)

الموضوعات:

Distribution of one-way public transit travel times to opioid treatment programs and expanded methadone treatment access, New York City, 2024. حسب Marcus A. Bachhuber (8339127)

الموضوعات:

One-way public transit travel time to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. حسب Marcus A. Bachhuber (8339127)

الموضوعات:

One-way public transit travel time to opioid treatment programs and expanded methadone treatment access by percentile, New York City, 2024. حسب Marcus A. Bachhuber (8339127)

الموضوعات:

Mean difference in one-way public transit travel time between opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. حسب Marcus A. Bachhuber (8339127)

الموضوعات:

Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... حسب Wen-Han Yan (20539256)

الموضوعات:

Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... حسب Wen-Han Yan (20539256)

الموضوعات:

Summary of the number of SMs, with those significantly loading the first two principle axes (PC) of PCA also indicated. حسب Nisa Leksungnoen (18966403)

الموضوعات:

Temporal trends of risk of financial toxicity (FT) between insured and uninsured patients, 2016–2019; no significant trends noted. حسب Alberto Romo Valenzuela (17879523)

List of metabolites deemed as significant discriminators (VIP>1) between insect and non-insect metabolome as per the PLSDA. حسب Nisa Leksungnoen (18966403)

الموضوعات:

Significant inequalities relating mental health and cognitive function (estimated scores and 95% confidence intervals, adjusted for all available covariates). حسب Brian Beach (11029132)

الموضوعات:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

Stepwise multiple linear regression results for the significant relationships between physical fitness characteristics and modified Australian football kicking and handballing test... حسب Jessica B. Farley (8717574)

الموضوعات: